SCHEMBL5812432

SCHEMBL5812432

O=C(Cl)c1ccc(OC(F)F)c2oc3ccc(S(=O)(=O)NC4CC4)cc3c12

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.47
PDE4B Q07343 6/20 0.45
ALDH1A1 P00352 1/20 0.42
PDE4A P27815 2/20 0.38
PDE4C Q08493 2/20 0.38
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.35
PARG Q86W56 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
GAA P10253 2/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5822481 0.92 ALDH1A1 (0.47) PDE4DPDE4BALDH1A1PDE4APDE4C
Hydrochloric Acid SCHEMBL5812436 0.91 ALDH1A1 (0.46) PDE4DPDE4BALDH1A1PDE4APDE4C
SCHEMBL5809786 0.86 PDE4D (0.51) PDE4DPDE4BALDH1A1PDE4APDE4C
SCHEMBL5797163 0.78 PDE4D (0.47) PDE4DPDE4BALDH1A1PDE4APDE4C
Hydrochloric Acid SCHEMBL5809789 0.77 PDE4D (0.47) PDE4DPDE4BALDH1A1PDE4APDE4C
SCHEMBL13620937 0.75 PDE4D (0.46) PDE4DPDE4BALDH1A1PDE4APDE4C
SCHEMBL5808233 0.73 PDE4D (0.44) PDE4DALDH1A1KMT2AMAPTGAA
SCHEMBL3306175 0.70 PDE4D (0.69) PDE4DPDE4BALDH1A1PDE4APDE4C
SCHEMBL8268461 0.69 PDE4D (0.65) PDE4DPDE4BPDE4APDE4C
SCHEMBL5795878 0.69 PDE4D (0.39) PDE4DPDE4BALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006051390-A1 HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF PREPARING THEM GLENMARK PHARMACEUTICALS S.A. (US) 2006-05-18 WO disclosed